Wolfgang G Junger1, Shawn G Rhind, Sandro B Rizoli, Joseph Cuschieri, Andrew J Baker, Pang N Shek, David B Hoyt, Eileen M Bulger. 1. *Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School and Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria; †Defence Research and Development Canada, Toronto Research Centre and ‡Departments of Surgery and Critical Care Medicine, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; §Department of Surgery, Harborview Medical Center, University of Washington, Seattle, Washington; ∥Brain Injury Laboratory, Cara Phelan Centre for Trauma Research Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada; and ¶American College of Surgeons, Department of Surgery, University of California, Irvine, California.
Abstract
BACKGROUND: Activation of polymorphonuclear neutrophils (PMNs) is thought to contribute to traumatic brain injury (TBI). Since hypertonic fluids can inhibit PMN activation, we studied whether hypertonic fluid resuscitation can reduce excessive PMN activation in TBI patients. METHODS:Trauma patients with severe TBI were resuscitated with 250 mL of either 7.5% hypertonic saline (HS; n = 22), HS + 6% dextran-70 (HSD; n = 22), or 0.9% normal saline (NS; n = 39), and blood samples were collected on hospital admission and 12 and 24 h after resuscitation. Polymorphonuclear neutrophil activation (CD11b, CD62L, CD64) and degranulation (CD63, CD66b, CD35) markers and oxidative-burst activity, as well as spontaneous PMN apoptosis were measured by flow cytometry. RESULTS: Relative to healthy controls, TBI patients showed increased PMN activation and decreased apoptosis of PMNs. In the HS group, but not in the HSD group, markers of PMN adhesion (CD11b, CD64) and degranulation (CD35, CD66b) were significantly lower than those in the NS group. These effects were particularly pronounced 12 h after resuscitation. Treatment with HS and HSD inhibited PMN oxidative burst responses compared with NS-treated patients. Hypertonic saline alone partially restored delayed PMN apoptosis. Despite these differences, the groups did not differ in clinical outcome parameters such as mortality and Extended Glasgow Outcome Scale. CONCLUSIONS: This study demonstrates that prehospital resuscitation with HS can partially restore normal PMN activity and the apoptotic behavior of PMNs, whereas resuscitation with HSD was largely ineffective. Although the results are intriguing, additional research will be required to translate these effects of HS into treatment strategies that improve clinical outcome in TBI patients.
RCT Entities:
BACKGROUND: Activation of polymorphonuclear neutrophils (PMNs) is thought to contribute to traumatic brain injury (TBI). Since hypertonic fluids can inhibit PMN activation, we studied whether hypertonic fluid resuscitation can reduce excessive PMN activation in TBIpatients. METHODS:Traumapatients with severe TBI were resuscitated with 250 mL of either 7.5% hypertonicsaline (HS; n = 22), HS + 6% dextran-70 (HSD; n = 22), or 0.9% normal saline (NS; n = 39), and blood samples were collected on hospital admission and 12 and 24 h after resuscitation. Polymorphonuclear neutrophil activation (CD11b, CD62L, CD64) and degranulation (CD63, CD66b, CD35) markers and oxidative-burst activity, as well as spontaneous PMN apoptosis were measured by flow cytometry. RESULTS: Relative to healthy controls, TBIpatients showed increased PMN activation and decreased apoptosis of PMNs. In the HS group, but not in the HSD group, markers of PMN adhesion (CD11b, CD64) and degranulation (CD35, CD66b) were significantly lower than those in the NS group. These effects were particularly pronounced 12 h after resuscitation. Treatment with HS and HSD inhibited PMN oxidative burst responses compared with NS-treated patients. Hypertonicsaline alone partially restored delayed PMN apoptosis. Despite these differences, the groups did not differ in clinical outcome parameters such as mortality and Extended Glasgow Outcome Scale. CONCLUSIONS: This study demonstrates that prehospital resuscitation with HS can partially restore normal PMN activity and the apoptotic behavior of PMNs, whereas resuscitation with HSD was largely ineffective. Although the results are intriguing, additional research will be required to translate these effects of HS into treatment strategies that improve clinical outcome in TBIpatients.
Authors: Tatjana Orlic; William H Loomis; Amy Shreve; Sachiko Namiki; Wolfgang G Junger Journal: Am J Physiol Cell Physiol Date: 2002-06 Impact factor: 4.249
Authors: Walter L Biffl; Rachel Carnaggio; Ernest E Moore; David J Ciesla; Jeffrey L Johnson; Christopher C Silliman Journal: Surgery Date: 2003-07 Impact factor: 3.982
Authors: D James Cooper; Paul S Myles; Francis T McDermott; Lynette J Murray; John Laidlaw; Gregory Cooper; Ann B Tremayne; Stephen S Bernard; Jennie Ponsford Journal: JAMA Date: 2004-03-17 Impact factor: 56.272
Authors: Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek Journal: Nat Rev Neurol Date: 2017-02-10 Impact factor: 42.937
Authors: Rodney M Ritzel; Sarah J Doran; James P Barrett; Rebecca J Henry; Elise L Ma; Alan I Faden; David J Loane Journal: J Neurotrauma Date: 2018-05-03 Impact factor: 5.269
Authors: B Relja; R Taraki; M P J Teuben; K Mörs; N Wagner; S Wutzler; F Hildebrand; M Perl; I Marzi Journal: BMC Pulm Med Date: 2016-12-01 Impact factor: 3.317
Authors: Jon Hazeldine; David N Naumann; Emma Toman; David Davies; Jonathan R B Bishop; Zhangjie Su; Peter Hampson; Robert J Dinsdale; Nicholas Crombie; Niharika Arora Duggal; Paul Harrison; Antonio Belli; Janet M Lord Journal: PLoS Med Date: 2017-07-18 Impact factor: 11.069